Pharmaceuticals Lumryz Demonstrated Superiority Over Oxybate in Treating Narcolepsy Last updated: September 3, 2024 6:35 pm By bexib 0 Min Read Share SHARE Results from the RESTORE study revealed that 94% of participants preferred Lumryz over twice-nightly oxybate treatment for treating narcolepsy. You Might Also Like APL and CurifyLabs Partner to Support Patients with 3D Printed Medical Technology Phase 2 PREDICT-ILD Imaging Study in Interstitial Lung Disease Begins New ways to determine drug value with health equity in mind Melissa Krebs Shares Gersana’s Vision for Innovative Wound Care Solutions Zongertinib demonstrates high objective response rates in previously treated advanced non-small cell lung cancer Share This Article Facebook Twitter Email Print Previous Article 2:00 PM The Water Cooler September 3, 2024 | Naked Capitalism Next Article US bank develops AI tools to meet small business demand Leave a comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Stay ConnectedFacebookLikeTwitterFollowYoutubeSubscribeTelegramFollowLatest News A look inside: Allies developing a multicloud hybrid strategy Banking 2024 Holiday Shipping Deadline for the United States International Shipping Ecommerce taxes – How to stay ahead of the sales tax maze Retail & E-commerce Finastra breach: 3 security points Banking